327 Nociplastic pain and early discontinuation of aromatase inhibitor therapy in breast cancer patients over age 65

by Elizabeth Joyce, Kelley M. Kidwell, N. Lynn Henry
Published 2022-04-01

2043

by Daniel L. Hertz, Kelley M. Kidwell, Kiran Vangipuram, Duxin Sun, N. Lynn Henry
Published 2017-09-01

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

by Márcio A. Diniz, Gillian Gresham, Sungjin Kim, Michael Luu, N. Lynn Henry, Mourad Tighiouart, Greg Yothers, Patricia A. Ganz, André Rogatko
Published 2021-11-01

Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

by N. Lynn Henry, Sungjin Kim, Ron D. Hays, Marcio A. Diniz, Mourad Tighiouart, Gillian Gresham, Michael Luu, Reena S. Cecchini, Greg Yothers, André Rogatko, Patricia A. Ganz
Published 2022-11-01

Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer

by Daniel L. Hertz, Karen Lisa Smith, Yuhua Zong, Christina L. Gersch, Andrea M. Pesch, Jennifer Lehman, Amanda L. Blackford, N. Lynn Henry, Kelley M. Kidwell, James M. Rae, Vered Stearns
Published 2021-06-01

Integrative Oncology Education: An Emerging Competency for Oncology Providers

by Safiya Karim, Rita Benn, Linda E. Carlson, Judith Fouladbakhsh, Heather Greenlee, Rick Harris, N. Lynn Henry, Shruti Jolly, Sabrina Mayhew, Lisa Spratke, Eleanor M. Walker, Bradley Zebrack, Suzanna M. Zick
Published 2021-02-01

Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot stud...

by Teresa M. Salgado, Jin Liu, Holly L. Reed, Caroline S. Quinn, Jillian G. Syverson, Jennifer Le-Rademacher, Camden L. Lopez, Andreas S. Beutler, Charles L. Loprinzi, Kiran Vangipuram, Ellen M. Lavoie Smith, N Lynn Henry, Karen B. Farris, Daniel L. Hertz
Published 2020-06-01

Genetic variations that influence paclitaxel pharmacokinetics and intracellular effects that may contribute to chemotherapy-induced neuropathy: A narrative review

by Ken B. Johnson, Anukriti Sharma, N. Lynn Henry, Mei Wei, Bihua Bie, Courtney E. Hershberger, Emily E. Rhoades, Alper Sen, Ryan E. Johnson, Jacob Steenblik, Jennifer Hockings, Jennifer Hockings, G. Thomas Budd, Charis Eng, Joseph Foss, Daniel M. Rotroff, Daniel M. Rotroff, Daniel M. Rotroff
Published 2023-05-01

Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance

by Costanza Paoletti, Jose M. Larios, Maria C. Muñiz, Kimberly Aung, Emily M. Cannell, Elizabeth P. Darga, Kelley M. Kidwell, Dafydd G. Thomas, Nahomi Tokudome, Martha E. Brown, Mark C. Connelly, David A. Chianese, Anne F. Schott, N. Lynn Henry, James M. Rae, Daniel F. Hayes
Published 2016-08-01

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI...

by Siu-Fun Wong, Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries, Anna Moseley, Kathryn Arnold, Mario R. Velasco, Justin D. Floyd, Benjamin T. Esparaz, Afsaneh Barzi, Heinz-Josef Lenz, Marianna Koczywas, Shaker Dakhil, Gary V. Burton, Michael J. Fisch, N. Lynn Henry, Dawn L. Hershman, Carol M. Moinpour
Published 2020-07-01

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol

by Anukriti Sharma PhD, Ken B. Johnson MD, Bihua Bie MD, PhD, Emily E. Rhoades PhD, Alper Sen MD, Yuri Kida MS, Jennifer Hockings PharmD, PhD, Alycia Gatta BS, Jacqueline Davenport MS, Connie Arcangelini BS, Jennifer Ritzu BS, Jennifer DeVecchio BS, Ron Hughen BS, Mei Wei MD, G. Thomas Budd MD, N. Lynn Henry MD, Charis Eng MD, PhD, Joseph Foss MD, Daniel M. Rotroff PhD
Published 2022-09-01